INVITATION 

Dear Colleagues,

Systemic Autoimmune Rheumatic Diseases associated with Interstitial Lung Disease (SARD-ILD) represent a rapidly evolving and critical clinical domain demanding a coordinated, multidisciplinary approach. Clarifying updated pathophysiological mechanisms, establishing standardized early diagnostic pathways, and integrating targeted immunomodulatory alongside antifibrotic therapies are essential steps toward improving long-term patient outcomes across Europe and beyond.

Endorsed by the European Alliance of Associations for Rheumatology (EULAR), this specialized educational course is designed to meet international standards of excellence in clinical rheumatology and pulmonary care.